Read more about this drug that targets advanced breast cancer, and, specifically, patients who have not had success with Tamoxifen® or aromatase inhibitors (e.g. Arimidex®). To date, through the Phase II trials, it has shown effectiveness and tolerable side effects. … Continue reading →